GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amicus Therapeutics Inc (STU:AM6) » Definitions » Net Interest Income (for Banks)

Amicus Therapeutics (STU:AM6) Net Interest Income (for Banks)


View and export this data going back to 2013. Start your Free Trial

What is Amicus Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Amicus Therapeutics (STU:AM6) Business Description

Traded in Other Exchanges
Address
3675 Market Street, Philadelphia, PA, USA, 19104
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.